Radiological dynamics and SITC-defined resistance types of advanced melanoma during anti-PD-1 monotherapy: an independent single-blind observational study on an international cohort

BACKGROUND: Although the Society for Immunotherapy of Cancer (SITC) Immunotherapy Resistance Taskforce recently defined primary and secondary resistance to anti-programmed cell death protein 1 (anti-PD-1) therapy, there is lack of real-world data regarding differences in these resistance subtypes wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Xue, Kim, Michelle, Kasumova, Gyulnara, Si, Lu, Tang, Bixia, Cui, Chuanliang, Yang, Xiaoling, Wei, Xiaoting, Cohen, Justine, Lawrence, Donald, Freedman, Christine, Fadden, Riley, Rubin, Krista, Sharova, Tatyana, Frederick, Dennie, Flaherty, Keith, Sullivan, Ryan, Guo, Jun, Boland, Genevieve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908917/
https://www.ncbi.nlm.nih.gov/pubmed/33632901
http://dx.doi.org/10.1136/jitc-2020-002092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908917/
https://www.ncbi.nlm.nih.gov/pubmed/33632901
http://dx.doi.org/10.1136/jitc-2020-002092

Ejemplares similares